Published in Eur Respir J on March 01, 1999
Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax (2002) 3.58
Non-eosinophilic asthma: importance and possible mechanisms. Thorax (2002) 3.53
Cost-effectiveness of various diagnostic approaches for occupational asthma. Can Respir J (2007) 0.99
Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants. Thorax (2002) 0.97
A kit to facilitate and standardize the processing of sputum for measurement of airway inflammation. Can Respir J (2013) 0.82
Diagnostic approach in cases with suspected work-related asthma. J Occup Med Toxicol (2013) 0.78
Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease. Rheumatol Int (2011) 0.76
Comparison between Airway Responses to High versus Low Molecular Weight Compounds in Occupational Asthma. J Allergy (Cairo) (2011) 0.75
The case for confirming occupational asthma: why, how much, how far? (revisited) Eur Respir J (1999) 0.75
Asthma in the workplace: a Canadian contribution and perspective. Can Respir J (2007) 0.75
Assessing and treating work-related asthma. Allergy Asthma Clin Immunol (2008) 0.75
Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy (1977) 14.37
Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med (1996) 5.69
Inhibitory effects of disodium cromoglycate on allergen-inhalation tests. Lancet (1968) 5.08
Reproducibility and comparison of responses to inhaled histamine and methacholine. Thorax (1978) 4.77
Bird breeder's (fancier's) lung. Lancet (1966) 4.68
Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy (1977) 4.42
Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax (1992) 4.30
The perception of breathlessness in asthma. Am Rev Respir Dis (1982) 4.17
Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol (1981) 4.03
Mites and house-dust allergy. Lancet (1968) 4.01
The use of induced sputum to investigate airway inflammation. Thorax (1997) 3.85
Allergic reactions of the lungs to enzymes of Bacillus subtilis. Lancet (1969) 3.59
The assessment and treatment of asthma: a conference report. J Allergy Clin Immunol (1990) 3.40
A comparison of active and simulated chiropractic manipulation as adjunctive treatment for childhood asthma. N Engl J Med (1998) 3.29
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J (2006) 3.09
Chronic cough: eosinophilic bronchitis without asthma. Lancet (1989) 3.07
Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax (1981) 3.06
Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol (1982) 2.84
Standardization of inhalation provocation tests: two techniques of aerosol generation and inhalation compared. Am Rev Respir Dis (1981) 2.75
The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy (1994) 2.58
Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre. Thorax (1982) 2.53
Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination. Eur Respir J (1996) 2.46
Acute asthma: emergency department management and prospective evaluation of outcome. CMAJ (1990) 2.45
Diagnostic testing in chronic urticaria and angioedema. CMAJ (1992) 2.27
Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis (1990) 2.23
Late asthmatic responses. Am Rev Respir Dis (1987) 2.05
Protective effect of drugs on histamine-induced asthma. Thorax (1977) 2.02
The radiological appearances in allergic broncho-pulmonary aspergillosis. Clin Radiol (1970) 1.97
Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med (1996) 1.97
Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol (1973) 1.96
Nonvalidated food allergy tests. CMAJ (1988) 1.94
Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med (2000) 1.93
Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med (1998) 1.90
Prevalence of asthma, rhinitis and eczema among children in 2 Canadian cities: the International Study of Asthma and Allergies in Childhood. CMAJ (1999) 1.84
Candida albicans precipitins in respiratory disease in man. J Allergy (1968) 1.82
Canadian Thoracic Society guidelines for occupational asthma. Can Respir J (1998) 1.80
Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med (1998) 1.72
The spectrum of IgE-mediated responses to latex. JAMA (1991) 1.71
Fatal reaction to peanut antigen in almond icing. CMAJ (1988) 1.70
Standardised methodology of sputum induction and processing. Eur Respir J Suppl (2002) 1.70
Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J (2000) 1.69
Prednisone-dependent asthma: inflammatory indices in induced sputum. Eur Respir J (1999) 1.68
Asthma and increases in nonallergic bronchial responsiveness from seasonal pollen exposure. J Allergy Clin Immunol (1983) 1.67
Standardization of inhalation provocation tests: influence of nebulizer output, particle size, and method of inhalation. J Allergy Clin Immunol (1981) 1.66
Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol (1983) 1.65
Airway inflammation in symptomatic and asymptomatic children with methacholine hyperresponsiveness. Eur Respir J (1993) 1.65
Exacerbations of asthma without sputum eosinophilia. Thorax (1995) 1.63
Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage. Br J Anaesth (2004) 1.63
Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis (1987) 1.62
Asthma, COPD and bronchitis are just components of airway disease. Eur Respir J (2006) 1.60
Bronchial responsiveness to inhaled histamine and exercise. J Allergy Clin Immunol (1979) 1.60
Selectivity of beta adrenoreceptor antagonist drugs assessed by histamine bronchial provocation. Clin Pharmacol Ther (1979) 1.60
Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis (1979) 1.57
GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry (2005) 1.56
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy (2012) 1.55
Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax (1984) 1.55
Dimethyl ethanolamine-induced asthma. Am Rev Respir Dis (1977) 1.53
Asthma induced by cold air and its relation to nonspecific bronchial responsiveness to methacholine. Am Rev Respir Dis (1982) 1.51
Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. Br J Anaesth (2005) 1.50
Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J (1999) 1.48
Induced sputum: validity of fluid-phase IL-5 measurement. J Allergy Clin Immunol (2000) 1.47
Airway hyperresponsiveness. Relevance of random population data to clinical usefulness. Am Rev Respir Dis (1990) 1.45
A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol (2000) 1.45
Indirect airway challenges. Eur Respir J (2003) 1.42
Assessment and treatment of asthma. Can Fam Physician (1979) 1.41
Life-threatening asthma, urticaria, and angiooedema after ketoprofen. Lancet (1978) 1.40